Transition Therapeutics Inc.
) was a big mover last session with shares rising roughly 7% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This continues the recent
uptrend for the company, as the stock is now up over 11% in the
past one month time frame.
This biopharmaceutical company has not seen any estimate revision
over the last 30 days. The Zacks Consensus Estimate also remained
unchanged over the same time frame. Yesterday's rally is
encouraging though, so make sure to keep a close watch on this
stock in the near future.
Transition Therapeutics currently holds a Zacks Rank #3 (Hold)
However, some better-ranked stocks in the BioMed industry include
). While Actelion and Heska sport a Zacks Rank #1 (Strong Buy),
Agenus carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
AGENUS INC (AGEN): Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
HESKA CORP (HSKA): Free Stock Analysis Report
TRANSITN THERAP (TTHI): Get Free Report
To read this article on Zacks.com click here.